Detail Information of Post-Translational Modifications
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0292 Transporter Info | ||||
Gene Name | SLC35B1 | ||||
Transporter Name | UDP-galactose transporter-related protein 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Post-Translational Modification of This DT | |||||
Overview of SLC35B1 Modification Sites with Functional and Structural Information | |||||
Sequence |
MASSSSLVPD RLRLPLCFLG VFVCYFYYGI LQEKITRGKY GEGAKQETFT FALTLVFIQC
VINAVFAKIL IQFFDTARVD RTRSWLYAAC SISYLGAMVS SNSALQFVNY PTQVLGKSCK PIPVMLLGVT LLKKKYPLAK YLCVLLIVAG VALFMYKPKK VVGIEEHTVG YGELLLLLSL TLDGLTGVSQ DHMRAHYQTG SNHMMLNINL WSTLLLGMGI LFTGELWEFL SFAERYPAII YNILLFGLTS ALGQSFIFMT VVYFGPLTCS IITTTRKFFT ILASVILFAN PISPMQWVGT VLVFLGLGLD AKFGKGAKKT SH |
||||
PTM type |
X-Phosphorylation
X: Amino Acid
|
Phosphorylation |
|||||
---|---|---|---|---|---|
Tyrosine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC35B1 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
27 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC35B1 Tyrosine 27 has the potential to affect its expression or activity. | ||||
References | |||||
---|---|---|---|---|---|
1 | Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.